2019
DOI: 10.1016/j.talanta.2019.05.087
|View full text |Cite
|
Sign up to set email alerts
|

An rGONS-based biosensor for simultaneous imaging of p53 and p21 mRNA in living cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…Herein, a reduced graphene oxide nanosheet (rGONS)–modified nanosystem is constructed for in situ and real-time p53 and p21 mRNA imaging by adsorbing the FAM-labeled p21 probe (P21) and Cy5-labeled p53 probe (P53). Once the two fluorescence probes hybridize with corresponding targets, the formation of DNA/RNA duplexes directly facilitates the release of probes from the rGONS surface and then restores the fluorescence signal ( Fan et al, 2019 ). Therefore, the nanosystem in situ reveals a p53 and p21 mRNA–related regulatory process, which is practicable for drug screening and therapy evaluation in clinics.…”
Section: The Application Of Nucleic Acid Probe–based Fluorescent Imaging In Cancer Diagnosis and Treatmentmentioning
confidence: 99%
“…Herein, a reduced graphene oxide nanosheet (rGONS)–modified nanosystem is constructed for in situ and real-time p53 and p21 mRNA imaging by adsorbing the FAM-labeled p21 probe (P21) and Cy5-labeled p53 probe (P53). Once the two fluorescence probes hybridize with corresponding targets, the formation of DNA/RNA duplexes directly facilitates the release of probes from the rGONS surface and then restores the fluorescence signal ( Fan et al, 2019 ). Therefore, the nanosystem in situ reveals a p53 and p21 mRNA–related regulatory process, which is practicable for drug screening and therapy evaluation in clinics.…”
Section: The Application Of Nucleic Acid Probe–based Fluorescent Imaging In Cancer Diagnosis and Treatmentmentioning
confidence: 99%
“…Fana et al [40] also synthesized reduced graphene oxide-based biosensors to diagnose liver cancer. Graphene oxides are preferred as nanoparticles due to their electronic, mechanical and thermal stability.…”
Section: Biosensorsmentioning
confidence: 99%
“…High-sensitivity nonenzymatic hydrogen peroxide biosensor [37] Detection of single nucleotide polymorphism of tumor Gold probe with lateral flow strip biosensor [39] For simultaneous imaging of P53 and P21 mRNA in living cells An RGONS-based biosensor [40] Detection of lysozyme Aptamer-based electrochemical biosensors [41] Detection of arsenic and mercury Metallothionein-based biosensor [42] Detection of malachite green Free microcantilever based biosensor [43] Refractive index sensor A single-layer guided-mode resonant optical biosensor [44] The determination of 3methylquinoxaline-2-carboxylic acid Surface plasmon resonance biosensor [45] Detection of escherichia coli Label-free amperometric biosensor [46] Electrochemical detection of the human cancer biomarker…”
Section: Purpose Of Usage Biosensors Referencesmentioning
confidence: 99%
“…18 On the other hand, due to the complexity of the intracellular environment, the signal output in cells is weak to a certain extent, which makes it prone to generate a false positive signal. 19 Therefore, a more reliable platform for the real-time observation of mRNA in living cells would be of great significance.…”
Section: Introductionmentioning
confidence: 99%
“…Reduced graphene oxide nanosheet-assisted fluorescence probes were used to detect levels of p53 and p21 mRNA in HepG2 cells by Wang's group. 19 Tang et al employed a multicolored fluorescence nanoprobe based on AuNPs for simultaneously detecting three tumor-related mRNAs (c-myc mRNA, TK1 mRNA and GalNAc-T mRNA). 25 These two literature reports provide a novel method for mRNA detection by using different nanomaterials; however, the methods were complicated and needed more time to complete the response reaction.…”
Section: Introductionmentioning
confidence: 99%